Editorial
Open access
Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies
Medicine
Abstract
the importance of clinicopathological characterization and biomarker discovery. Emerging pharmacological approaches, including EZH2 inhibition, PARP-directed combination therapies, and natural product-based therapies such as (+)-PTC, may restore therapeutic sensitivity and ultimately contribute to precision oncology and improved patient outcomes.